Regression of Myocardial<sup>99m</sup>Tc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis-Reference-Cited by-同舟云学术

Regression of Myocardial^99mTc-DPD Uptake After Tafamidis Treatment of Cardiac Transthyretin Amyloidosis

Published:2023-06-08 Issue:7 Volume:64 Page:1083-1086
ISSN:0161-5505
Container-title:Journal of Nuclear Medicine
language:en
Short-container-title:J Nucl Med

Author:

Papathanasiou Maria,Kessler Lukas,Bengel Frank M.,Jakstaite Aiste-Monika,Kersting David,Varasteh Zohreh,Luedike Peter,Carpinteiro Alexander,Herrmann Ken,Rassaf Tienush,Rischpler Christoph

Publisher

Society of Nuclear Medicine

Subject

Radiology, Nuclear Medicine and imaging

Reference8 articles.

1. Expert consensus on the monitoring of transthyretin amyloid cardiomyopathy;Garcia-Pavia;Eur J Heart Fail.,2021

2. Reduction in CMR derived extracellular volume with patisiran indicates cardiac amyloid regression;Fontana;JACC Cardiovasc Imaging.,2021

3. Tafamidis treatment delays structural and functional changes of the left ventricle in patients with transthyretin amyloid cardiomyopathy;Rettl;Eur Heart J Cardiovasc Imaging.,2022

4. DPD Quantification in Cardiac Amyloidosis

5. Quantitative 99mTc-DPD-SPECT/CT assessment of cardiac amyloidosis;Kessler;J Nucl Cardiol.,2023

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Nuklearmedizinische Bildgebungsverfahren für die Kardiologie;Kardiologie up2date;2024-09

2. Response to therapy with tafamidis 61 mg in patients with cardiac transthyretin amyloidosis: real-world experience since approval;Amyloid;2024-07-02

3. Cardiac Biomarker Change at 1 Year After Tafamidis Treatment and Clinical Outcomes in Patients With Transthyretin Amyloid Cardiomyopathy;Journal of the American Heart Association;2024-05-21

4. Deep Learning–Enabled Quantification of^99mTc-Pyrophosphate SPECT/CT for Cardiac Amyloidosis;Journal of Nuclear Medicine;2024-05-09

5. Prognostic Value of [^99mTc]Tc-DPD Quantitative SPECT/CT in Patients with Suspected and Confirmed Amyloid Transthyretin–Related Cardiomyopathy and Preserved Left Ventricular Function;Journal of Nuclear Medicine;2024-05-09